title: Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.
abstract: The activity of many anti-infectious drugs has been compromised by the evolution of multidrug-resistant (MDR) pathogens. For life-threatening fungal infections, such as those caused by Candida albicans, overexpression of MDR1, which encodes an MDR efflux pump of the major facilitator superfamily (MFS), often confers resistance to chemically unrelated substances, including the most commonly used azole antifungals. As the development of new and efficacious antifungals has lagged far behind the growing emergence of resistant strains, it is imperative to develop strategies to overcome multidrug resistance. Previous advances have been mainly to deploy combinational therapy to restore azole susceptibility, which, however, requires coordination of two or more compounds. We observed a unique phenotype in which Mdr1p facilitates the uptake of a specific class of compounds. Among them, we describe a novel antifungal small molecule, bis[1,6-a:5',6'-g]quinolizinium 8-methyl-salt (BQM) (U.S. patent application no. 61/793,090,2013), that has potent and broad antifungal activity. Notably, BQM exploits the MDR phenotype in C. albicans to promote the inhibitory effect. Rather than causing an antagonism of MDR strains, it exhibits a highly potentiated activity against a collection of clinical isolates and lab strains that overexpress MDR1. The activity of BQM against MDR1-overexpressing isolates is due to its facilitated intracellular accumulation. Microarray comparisons showed an extensive upregulation of MDR1 as well as polyamine transporter genes in a fluconazole-resistant strain. We then demonstrated that the polyamine transporters augment the accumulation of BQM. Importantly, BQM had greater activity than fluconazole and itraconazole against various fungal pathogens, including MDR Aspergillus fumigatus. Thus, our findings offer a paradigm shift to overcome MDR and the promise of improving antifungal treatment, especially in MDR pathogens.
authors.affiliation: Georgetown University Medical Center, Department of Microbiology & Immunology, Washington, DC, USA.
authors.forename: Nuo
authors.initials: N
authors.lastname: Sun
authors.forename: Dongmei
authors.initials: D
authors.lastname: Li
authors.forename: William
authors.initials: W
authors.lastname: Fonzi
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Lixin
authors.initials: L
authors.lastname: Zhang
authors.forename: Richard
authors.initials: R
authors.lastname: Calderone
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics* / Q000378:metabolism; D000935:Antifungal Agents / Q000494:pharmacology*; D001232:Aspergillus fumigatus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D052117:Benzodioxoles / Q000494:pharmacology*; D001692:Biological Transport; D002176:Candida albicans / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D025141:Drug Resistance, Fungal / Q000235:genetics; D015725:Fluconazole / Q000494:pharmacology; D005656:Fungal Proteins / Q000235:genetics* / Q000378:metabolism; D015966:Gene Expression Regulation, Fungal; D008826:Microbial Sensitivity Tests; D011807:Quinolizines / Q000494:pharmacology*; D054852:Small Molecule Libraries / Q000494:pharmacology*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000935:Antifungal Agents; D052117:Benzodioxoles; D005656:Fungal Proteins; C000593611:NSC156627; D011807:Quinolizines; D054852:Small Molecule Libraries; D014157:Transcription Factors; D015725:Fluconazole
references.citation: PLoS Pathog. 2007 Nov;3(11):e164
references.pmid: 17983269
references.citation: Antimicrob Agents Chemother. 2002 Jun;46(6):1704-13
references.pmid: 12019079
references.citation: Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9284-9
references.pmid: 12089321
references.citation: Antimicrob Agents Chemother. 2013 Jan;57(1):532-42
references.pmid: 23147730
references.citation: Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7
references.pmid: 9210670
references.citation: FEMS Yeast Res. 2006 May;6(3):345-55
references.pmid: 16630275
references.citation: Eukaryot Cell. 2011 Nov;10(11):1376-83
references.pmid: 21926328
references.citation: J Mol Microbiol Biotechnol. 2001 Apr;3(2):247-54
references.pmid: 11321580
references.citation: J Biol Chem. 2011 Dec 23;286(51):43748-43758
references.pmid: 22033918
references.citation: Microbiology (Reading). 2006 Dec;152(Pt 12):3701-3722
references.pmid: 17159223
references.citation: Antimicrob Agents Chemother. 2006 Apr;50(4):1365-71
references.pmid: 16569853
references.citation: Antimicrob Agents Chemother. 2009 Apr;53(4):1344-52
references.pmid: 19223631
references.citation: Clin Microbiol Rev. 1998 Apr;11(2):382-402
references.pmid: 9564569
references.citation: Antimicrob Agents Chemother. 1998 Dec;42(12):3065-72
references.pmid: 9835492
references.citation: Diagn Microbiol Infect Dis. 2010 Apr;66(4):373-84
references.pmid: 20226328
references.citation: Clin Infect Dis. 2013 Jun;56(12):1724-32
references.pmid: 23487382
references.citation: J Antimicrob Chemother. 2008 Aug;62(2):349-55
references.pmid: 18436555
references.citation: Antimicrob Agents Chemother. 2011 May;55(5):2212-23
references.pmid: 21402859
references.citation: Lancet Infect Dis. 2011 Feb;11(2):142-51
references.pmid: 21272794
references.citation: Nat Rev Microbiol. 2008 Mar;6(3):187-98
references.pmid: 18246082
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2818-23
references.pmid: 19196973
references.citation: Science. 2012 Sep 14;337(6100):1353-6
references.pmid: 22984072
references.citation: PLoS Genet. 2005 Jul;1(1):36-57
references.pmid: 16103911
references.citation: Sci Transl Med. 2012 Dec 19;4(165):165rv13
references.pmid: 23253612
references.citation: Med Clin (Barc). 2010 Jan 23;134(1):1-5
references.pmid: 19913258
references.citation: Eukaryot Cell. 2009 Nov;8(11):1706-20
references.pmid: 19717740
references.citation: Annu Rev Microbiol. 2002;56:139-65
references.pmid: 12142485
references.citation: Genetics. 1993 Jul;134(3):717-28
references.pmid: 8349105
references.citation: Clin Infect Dis. 2001 Apr 1;32(7):1110
references.pmid: 11264044
references.citation: Eukaryot Cell. 2011 May;10(5):672-82
references.pmid: 21398508
references.citation: J Biol Chem. 2005 Mar 11;280(10):9646-52
references.pmid: 15637075
references.citation: Mol Microbiol. 2000 May;36(4):856-65
references.pmid: 10844673
references.citation: Mol Microbiol. 2008 Aug;69(4):827-40
references.pmid: 18577180
references.citation: Nat Rev Drug Discov. 2010 Sep;9(9):719-27
references.pmid: 20725094
references.citation: Nat Rev Microbiol. 2005 Jul;3(7):547-56
references.pmid: 15953931
references.citation: Antimicrob Agents Chemother. 2012 Mar;56(3):1508-15
references.pmid: 22203607
references.citation: Antimicrob Agents Chemother. 2006 Jul;50(7):2300-8
references.pmid: 16801405
references.citation: Antimicrob Agents Chemother. 2002 Oct;46(10):3133-41
references.pmid: 12234835
references.citation: Biochem J. 1999 Dec 15;344 Pt 3:633-42
references.pmid: 10585849
references.citation: Antimicrob Agents Chemother. 2010 Apr;54(4):1476-83
references.pmid: 20086148
references.citation: Mol Cell Biol. 1997 Jun;17(6):2994-3004
references.pmid: 9154797
references.citation: Clin Microbiol Rev. 2009 Apr;22(2):291-321, Table of Contents
references.pmid: 19366916
references.citation: PLoS Pathog. 2010 Sep 30;6(9):e1001126
references.pmid: 20941354
references.citation: Virulence. 2010 Nov-Dec;1(6):475-82
references.pmid: 21178491
references.citation: Fungal Genet Biol. 2002 Jul;36(2):117-27
references.pmid: 12081465
references.citation: Fungal Genet Biol. 2012 Dec;49(12):1023-32
references.pmid: 23063955
references.citation: Nat Rev Microbiol. 2006 Jun;4(6):435-44
references.pmid: 16710324
references.citation: Fungal Genet Biol. 2007 Oct;44(10):979-90
references.pmid: 17254815
references.citation: Food Chem. 2013 Jun 15;138(4):2267-74
references.pmid: 23497885